Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial
A triple-action therapy (GIP + GLP-1 + Glucagon) currently under investigation, demonstrating up to ~24% weight reduction in early trials
Finally, a cyanocobalamin treatment may be necessary only in situations of vitamin B 12 deficiency, at a dosage of 0.4 to 2 mg per day, depending on the severity of the deficiency
Previous presentation: These data were presented in part as a poster at the Annual Meeting of the Endocrine Society
At what sales levels would TopHats prefer to pay a fixed amount of monthly rent, and at what sales levels would it prefer to pay 5% of its monthly revenue as rent